Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-90
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
About this trial
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Eligibility criteria
Qualifiers
Age ≥ 60 years;
Diagnosis of iNPH based on clinical assessment
Participant is able to give written informed consent
Disqualifiers
Combining AD and Parkinson's disease and other nervous system diseases
Participant is not medically available for shunt surgery
Secondary NPH
Trial design
Treatments tested in this trial
- ventriculo-peritoneal shunt
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
Westlake University
Collaborator
Source ClinicalTrials.gov